{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:48:59Z","timestamp":1793299739758,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Platon Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1245\/s10434-022-11323-8","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T20:24:07Z","timestamp":1645734247000},"page":"3337-3346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cytoreductive Surgery with HIPEC is a Safe and Effective Palliative Option in Chemorefractory Symptomatic Peritoneal Metastasis"],"prefix":"10.1245","volume":"29","author":[{"given":"Chunmeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asish","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton","family":"Hegeholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Shostrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory","family":"Pottebaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"issue":"2","key":"11323_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/jso.24813","volume":"117","author":"WF Morano","year":"2018","unstructured":"Morano WF, Khalili M, Chi DS, Bowne WB, Esquivel J. Clinical studies in CRS and HIPEC: trials, tribulations, and future directions: a systematic review. J Surg Oncol. 2018;117(2):245\u201359.","journal-title":"J Surg Oncol."},{"issue":"20","key":"11323_CR2","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737\u201343.","journal-title":"J Clin Oncol."},{"issue":"7","key":"11323_CR3","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1245\/s10434-018-6499-1","volume":"25","author":"V Verma","year":"2018","unstructured":"Verma V, Sleightholm RL, Rusthoven CG, et al. Malignant peritoneal mesothelioma: national practice patterns, outcomes, and predictors of survival. Ann Surg Oncol. 2018;25(7):2018\u201326.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"11323_CR4","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","volume":"22","author":"J Spiliotis","year":"2015","unstructured":"Spiliotis J, Halkia E, Lianos E, et al. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol. 2015;22(5):1570\u20135.","journal-title":"Ann Surg Oncol."},{"issue":"39","key":"11323_CR5","doi-asserted-by":"publisher","first-page":"14371","DOI":"10.3748\/wjg.v20.i39.14371","volume":"20","author":"C Terzi","year":"2014","unstructured":"Terzi C, Arslan NC, Canda AE. Peritoneal carcinomatosis of gastrointestinal tumors: Where are we now? World J Gastroenterol. 2014;20(39):14371\u201380.","journal-title":"World J Gastroenterol."},{"issue":"2","key":"11323_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358\u201363.","journal-title":"Cancer."},{"issue":"2","key":"11323_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Quenet","year":"2021","unstructured":"Quenet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366.","journal-title":"Lancet Oncol."},{"issue":"5","key":"11323_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jviscsurg.2014.07.005","volume":"151","author":"N Bakrin","year":"2014","unstructured":"Bakrin N, Classe JM, Pomel C, Gouy S, Chene G, Glehen O. Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer. J Visc Surg. 2014;151(5):347\u201353.","journal-title":"J Visc Surg."},{"issue":"7","key":"11323_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1517\/13543780902939151","volume":"18","author":"JM Davies","year":"2009","unstructured":"Davies JM, O\u2019Neil B. Peritoneal carcinomatosis of gastrointestinal origin: natural history and treatment options. Expert Opin Investig Drugs. 2009;18(7):913\u20139.","journal-title":"Expert Opin. Investig. Drugs."},{"issue":"12","key":"11323_CR10","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89(12):1545\u201350.","journal-title":"Br J Surg."},{"issue":"2","key":"11323_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V","volume":"63","author":"DZ Chu","year":"1989","unstructured":"Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989;63(2):364\u20137.","journal-title":"Cancer."},{"issue":"3","key":"11323_CR12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S1055-3207(03)00044-9","volume":"12","author":"O Glehen","year":"2003","unstructured":"Glehen O, Osinsky D, Beaujard AC, Gilly FN. Natural history of peritoneal carcinomatosis from nongynecologic malignancies. Surg Oncol Clin N Am. 2003;12(3):729\u201339.","journal-title":"Surg Oncol Clin N Am."},{"issue":"8","key":"11323_CR13","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1245\/s10434-018-6335-7","volume":"25","author":"LA Lambert","year":"2018","unstructured":"Lambert LA, Wiseman J. Palliative management of peritoneal metastases. Ann Surg Oncol. 2018;25(8):2165\u201371.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"11323_CR14","first-page":"141","volume":"80","author":"AM Averbach","year":"1995","unstructured":"Averbach AM, Sugarbaker PH. Recurrent intraabdominal cancer with intestinal obstruction. Int Surg. 1995;80(2):141\u20136.","journal-title":"Int. Surg."},{"issue":"8","key":"11323_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s10434-001-0632-1","volume":"8","author":"SL Blair","year":"2001","unstructured":"Blair SL, Chu DZ, Schwarz RE. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol. 2001;8(8):632\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"11323_CR16","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/bjs.5863","volume":"94","author":"RM Smeenk","year":"2007","unstructured":"Smeenk RM, Verwaal VJ, Zoetmulder FA. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg. 2007;94(11):1408\u201314.","journal-title":"Br J Surg."},{"issue":"2","key":"11323_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/SLA.0b013e3182436c28","volume":"255","author":"S Kusamura","year":"2012","unstructured":"Kusamura S, Baratti D, Deraco M. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg. 2012;255(2):348\u201356.","journal-title":"Ann Surg."},{"issue":"8","key":"11323_CR18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ejso.2014.03.001","volume":"40","author":"H Andreasson","year":"2014","unstructured":"Andreasson H, Lorant T, Pahlman L, Graf W, Mahteme H. Cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: aspects of the learning curve. Eur J Surg Oncol. 2014;40(8):930\u20136.","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"11323_CR19","doi-asserted-by":"publisher","first-page":"20190018","DOI":"10.1515\/pp-2019-0018","volume":"4","author":"J Spiliotis","year":"2019","unstructured":"Spiliotis J, Kalles V, Kyriazanos I, et al. CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: the small-bowel PCI score as a predictor of survival. Pleura Peritoneum. 2019;4(4):20190018.","journal-title":"Pleura Peritoneum."},{"issue":"11","key":"11323_CR20","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","volume":"40","author":"D Elias","year":"2014","unstructured":"Elias D, Mariani A, Cloutier AS, et al. Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. Eur J Surg Oncol. 2014;40(11):1467\u201373.","journal-title":"Eur J Surg Oncol."},{"key":"11323_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1477-7819-10-56","volume":"10","author":"EI Benizri","year":"2012","unstructured":"Benizri EI, Bernard JL, Rahili A, Benchimol D, Bereder JM. Small bowel involvement is a prognostic factor in colorectal carcinomatosis treated with complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2012;10:56.","journal-title":"World J Surg Oncol."},{"issue":"11","key":"11323_CR22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.crad.2017.07.005","volume":"72","author":"A Chandramohan","year":"2017","unstructured":"Chandramohan A, Thrower A, Smith SA, Shah N, Moran B. \u201cPAUSE\u201d: a method for communicating radiological extent of peritoneal malignancy. Clin Radiol. 2017;72(11):972\u201380.","journal-title":"Clin Radiol."},{"issue":"5","key":"11323_CR23","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1245\/s10434-013-3224-y","volume":"21","author":"RW Randle","year":"2014","unstructured":"Randle RW, Swett KR, Swords DS, et al. Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites. Ann Surg Oncol. 2014;21(5):1474\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"Pt A","key":"11323_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijsu.2015.09.074","volume":"23","author":"SJ Valle","year":"2015","unstructured":"Valle SJ, Alzahrani NA, Alzahrani SE, Liauw W, Morris DL. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery. Int J Surg. 2015;23(Pt A):176\u201380.","journal-title":"Int J Surg."},{"issue":"6","key":"11323_CR25","first-page":"530","volume":"181","author":"P Jacquet","year":"1995","unstructured":"Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg. 1995;181(6):530\u20138.","journal-title":"J Am Coll Surg."},{"issue":"1","key":"11323_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4251\/wjgo.v2.i1.31","volume":"2","author":"E Cotte","year":"2010","unstructured":"Cotte E, Passot G, Gilly FN, Glehen O. Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol. 2010;2(1):31\u20135.","journal-title":"World J Gastrointest Oncol."},{"issue":"4","key":"11323_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/jamasurg.2013.4059","volume":"149","author":"TJ Paul Olson","year":"2014","unstructured":"Paul Olson TJ, Pinkerton C, Brasel KJ, Schwarze ML. Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review. JAMA Surg. 2014;149(4):383\u201392.","journal-title":"JAMA Surg."},{"issue":"11","key":"11323_CR28","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1245\/s10434-019-07507-4","volume":"26","author":"JM Baumgartner","year":"2019","unstructured":"Baumgartner JM, Marmor R, Hsu A, Veerapong J, Kelly KJ, Lowy AM. Obstruction-free survival following operative intervention for malignant bowel obstruction in appendiceal cancer. Ann Surg Oncol. 2019;26(11):3611\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"11323_CR29","first-page":"488","volume":"23","author":"N Kopanakis","year":"2018","unstructured":"Kopanakis N, Argyriou EO, Vassiliadou D, et al. Quality of life after cytoreductive surgery and HIPEC: a single centre prospective study. J BUON. 2018;23(2):488\u201393.","journal-title":"J BUON."},{"issue":"16","key":"11323_CR30","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22(16):3284\u201392.","journal-title":"J Clin Oncol."},{"issue":"5","key":"11323_CR31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jamcollsurg.2006.12.048","volume":"204","author":"EA Levine","year":"2007","unstructured":"Levine EA, Stewart JH 4th, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007;204(5):943\u201353 (discussion 953\u2013945).","journal-title":"J Am Coll Surg."},{"issue":"3","key":"11323_CR32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1245\/s10434-007-9700-5","volume":"15","author":"BL van Leeuwen","year":"2008","unstructured":"van Leeuwen BL, Graf W, Pahlman L, Mahteme H. Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis. Ann Surg Oncol. 2008;15(3):745\u201353.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"11323_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1245\/ASO.2004.05.009","volume":"11","author":"P Shen","year":"2004","unstructured":"Shen P, Hawksworth J, Lovato J, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol. 2004;11(2):178\u201386.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11323-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-11323-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11323-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T14:27:04Z","timestamp":1649341624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-11323-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["11323"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-11323-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"assertion":[{"value":"26 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Chunmeng Zhang, Asish Patel, Dalton Hegeholz, Krista Brown, Valerie Shostrom, Mallory Pottebaum, and Jason M. Foster have no financial conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}